The patients were diagnosed using the WHO criteria of post-COVID (long COVID) [52], namely: (a) individuals having a history of proven SARS-CoV-2 infection, (b) symptoms persisted beyond the acute phase of illness or manifested during recovery from acute COVID-19 infection, (c) symptoms lasted at least 2 months and are present 34 months after the onset of COVID-19, and (d) patients suffer from at least two symptoms that impair daily functioning including fatigue, memory or concentration problems, shortness of breath, chest pain, persistent cough, difficulty speaking, muscle aches, loss of smell or taste, affective symptoms, cognitive impairment, or fever [52]
pmid:8958389 4
Research on VEGF and angiogenesis published in leading scientific journals has documented its essential role in tissue repair
Both BPC-157 and TB-500 are typically administered subcutaneously in research settings
These additions aim to provide comprehensive relief, helping you feel better more quickly